Tag Archives: Nimbus Therapeutics

Talent In The Biotech Gig Economy
January 31, 2017

This blog was written by Jeb Keiper, CBO of Nimbus Therapeutics LLC, as part of the From The Trenches feature of LifeSciVC. Walking the streets of Union Square in mid-January torrential rain, we had the good fortune of sharing the

6 Comments

Nimbus Delivers Its Apollo Mission: A $1.2B Gilead Partnership
April 4, 2016

Today Gilead announced the acquisition of Nimbus’ lead program targeting NASH and related metabolic disorders for $400M upfront and up to another $800M in development and regulatory milestones (here). This transformative deal is the culmination of over five years of work on

Leave a comment